<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fibrillin-1 is a 350 kDa calcium-binding protein which assembles to form 10-12 nm microfibrils in the extracellular matrix (ECM) </plain></SENT>
<SENT sid="1" pm="."><plain>The structure of fibrillin-1 is dominated by two types of <z:chebi fb="0" ids="48343">disulfide</z:chebi>-rich motifs, the calcium- binding epidermal growth factor-like (cbEGF) and transforming growth factor beta binding protein-like (TB) domains </plain></SENT>
<SENT sid="2" pm="."><plain>Disruption of fibrillin-1 domain structure and function contributes to the pathogenic mechanisms underlying two <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">inherited diseases</z:e> with very different etiologies: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) and <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> (HC) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> is a <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> caused by mutations in the fibrillin-1 gene FBN1 </plain></SENT>
<SENT sid="4" pm="."><plain>Many missense mutations cause variable degrees of fibrillin-1 domain misfolding, which may affect the delivery of fibrillin-1 to the ECM and/or its assembly into microfibrils </plain></SENT>
<SENT sid="5" pm="."><plain>HC is a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> which affects methionine metabolism and results in raised serum levels of the highly reactive <z:chebi fb="0" ids="29256">thiol</z:chebi>-containing amino acid <z:chebi fb="0" ids="17230">homocysteine</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with HC often exhibit ocular and skeletal defects resembling the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> phenotype, suggesting that elevated <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels may lead to chemical reduction of <z:chebi fb="0" ids="48343">disulfide</z:chebi> bonds within fibrillin-1 domains resulting in the loss of native structure </plain></SENT>
<SENT sid="7" pm="."><plain>Protein misfolding therefore is implicated in pathogenic mechanisms underlying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and HC </plain></SENT>
</text></document>